What is the recommended practice for antepartum anticoagulation in cases of non-recurring risk VTE?

In the case of a non-recurring risk for venous thromboembolism (VTE) during pregnancy, the recommended practice is to avoid anticoagulation treatment altogether. This approach is based on the understanding that the risk of VTE is not significant enough to warrant either prophylaxis or treatment with full anticoagulation.

For patients with non-recurring risk factors, the benefits of anticoagulation do not outweigh the potential risks, which can include bleeding complications and adverse effects on the pregnancy. Therefore, under such circumstances, routine monitoring is not indicated either, as the absence of notable risk means that the potential need for intervention is minimal. This is in contrast to populations with recurrent VTE risk, where prophylactic measures are often necessary to prevent complications. In summary, in the absence of significant risk factors for recurrent VTE, the recommendation is to refrain from any anticoagulation management.